US EditionThree-Year VenoValve(R) First-in-Human Trial Data Published in the Annals of Vascular Surgery
Summary by The Facts
2 Articles
2 Articles
All
Left
1
Center
1
Right
Three-Year VenoValve(R) First-in-Human Trial Data Published in the Annals of Vascular Surgery
Promising results from the first-in-human study demonstrated that, at three-years post implantation, VenoValve remained safe and effective--achieving a high rate of patency, restoring deep venous competence and maintaining clinical benefitsCompany has submitted PMA application for the VenoValve to the U.S.…
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
